These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15277339)

  • 41. The impact of hyperhomocysteinemia as a cardiovascular risk factor in the prediction of coronary heart disease.
    Geisel J; Hennen B; Hübner U; Knapp JP; Herrmann W
    Clin Chem Lab Med; 2003 Nov; 41(11):1513-7. PubMed ID: 14656034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute hyperhomocysteinaemia and endothelial dysfunction.
    Chambers JC; McGregor A; Jean-Marie J; Kooner JS
    Lancet; 1998 Jan; 351(9095):36-7. PubMed ID: 9433433
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg.
    Zylberstein DE; Bengtsson C; Björkelund C; Landaas S; Sundh V; Thelle D; Lissner L
    Circulation; 2004 Feb; 109(5):601-6. PubMed ID: 14769681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
    Leong T; Zylberstein D; Graham I; Lissner L; Ward D; Fogarty J; Bengtsson C; Björkelund C; Thelle D;
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):961-7. PubMed ID: 18292394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homocysteine as a risk factor for restenosis after coronary angioplasty.
    Morita H; Kurihara H; Kuwaki T; Hamada C; Kitaoka M; Suzuki S; Yazaki Y; Nagai R
    Thromb Haemost; 2000 Jul; 84(1):27-31. PubMed ID: 10928465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
    Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
    Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Involvement of homocysteine in the pathogenesis of hypertension and hypertensive target-organ damage].
    Saito Y; Kurabayashi M; Nakamura T; Morita H; Nagai R
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():211-5. PubMed ID: 15171371
    [No Abstract]   [Full Text] [Related]  

  • 48. Relative importance of risk factors for coronary heart disease--the Hordaland Homocysteine study.
    Igland J; Vollset SE; Nygård OK; Gjessing HK; Ueland PM; Tell GS
    Scand Cardiovasc J; 2012 Dec; 46(6):316-23. PubMed ID: 22881391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moderate hyperhomocysteinemia and cardiovascular disease.
    Tsai MY
    J Lab Clin Med; 2000 Jan; 135(1):16-25. PubMed ID: 10638690
    [No Abstract]   [Full Text] [Related]  

  • 50. Plasma homocysteine level and myocardial infarction: how high is high enough to need intervention?
    Ghosh K
    South Med J; 2006 Aug; 99(8):796-7. PubMed ID: 16929868
    [No Abstract]   [Full Text] [Related]  

  • 51. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction.
    Faraci FM; Lentz SR
    Stroke; 2004 Feb; 35(2):345-7. PubMed ID: 14757874
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
    Danesh J; Lewington S
    J Cardiovasc Risk; 1998 Aug; 5(4):229-32. PubMed ID: 9919470
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
    Woo KS; Sanderson JE; Sun YY; Chook P; Cheung AS; Chan LT; Metreweli C; Lolin YI; Celermajer DS
    Circulation; 2000 Mar; 101(12):E116. PubMed ID: 10736298
    [No Abstract]   [Full Text] [Related]  

  • 55. Homocysteine and endothelial function.
    Doshi SN; Goodfellow J; Lewis MJ; McDowell IF
    Cardiovasc Res; 1999 Jun; 42(3):578-82. PubMed ID: 10533596
    [No Abstract]   [Full Text] [Related]  

  • 56. Oestrogen and the cardiovascular system.
    Teede HJ; McGrath BP;
    Clin Sci (Lond); 2003 Jul; 105(1):9-10. PubMed ID: 12683948
    [No Abstract]   [Full Text] [Related]  

  • 57. Homocysteine: a risk factor for coronary artery disease?
    Marinou K; Antoniades C; Tousoulis D; Pitsavos C; Goumas G; Stefanadis C
    Hellenic J Cardiol; 2005; 46(1):59-67. PubMed ID: 15807397
    [No Abstract]   [Full Text] [Related]  

  • 58. Homocysteine and cardiovascular disease in diabetes mellitus.
    Jeremy JY; Shukla N; Angelini GD
    Atherosclerosis; 2002 Oct; 164(2):383-4. PubMed ID: 12204813
    [No Abstract]   [Full Text] [Related]  

  • 59. Is hyperhomocysteinemia a risk factor or a consequence of coronary heart disease?
    Cattaneo M
    Arch Intern Med; 2001 Nov; 161(21):2628-9. PubMed ID: 11718612
    [No Abstract]   [Full Text] [Related]  

  • 60. Homocysteine--an atherogenic and a thrombogenic factor?
    Ubbink JB
    Nutr Rev; 1995 Nov; 53(11):323-5. PubMed ID: 8643214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.